GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS)
CNY 19.33
(1.52%)
CNY 19.33
(1.52%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 818.48 Million CNY | -21.28% |
| 2022 | 990.51 Million CNY | 10.64% |
| 2021 | 895.29 Million CNY | 28.19% |
| 2020 | 698.38 Million CNY | -3.16% |
| 2019 | 721.21 Million CNY | -10.62% |
| 2018 | 806.9 Million CNY | 18.07% |
| 2017 | 683.42 Million CNY | 25.86% |
| 2016 | 542.99 Million CNY | 79.8% |
| 2015 | 301.99 Million CNY | 10.85% |
| 2014 | 272.43 Million CNY | 34.53% |
| 2013 | 202.5 Million CNY | 25.57% |
| 2012 | 161.26 Million CNY | 0.82% |
| 2011 | 159.95 Million CNY | 23.83% |
| 2010 | 129.17 Million CNY | -17.76% |
| 2009 | 157.07 Million CNY | -59.73% |
| 2008 | 390.06 Million CNY | 53.78% |
| 2007 | 253.65 Million CNY | -7.65% |
| 2006 | 274.65 Million CNY | 2.99% |
| 2005 | 266.66 Million CNY | -19.2% |
| 2004 | 330.01 Million CNY | 10.38% |
| 2003 | 298.98 Million CNY | 23.99% |
| 2002 | 241.13 Million CNY | -14.44% |
| 2001 | 281.83 Million CNY | 398.07% |
| 2000 | 56.58 Million CNY | 224.25% |
| 1999 | 17.45 Million CNY | 97.74% |
| 1998 | 8.82 Million CNY | 44.0% |
| 1997 | 6.12 Million CNY | 67.67% |
| 1996 | 3.65 Million CNY | 37.12% |
| 1995 | 2.66 Million CNY | 3.09% |
| 1994 | 2.58 Million CNY | 20.5% |
| 1993 | 2.14 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 220.03 Million CNY | 12.92% |
| 2024 Q1 | 194.85 Million CNY | 6.8% |
| 2024 Q3 | 187.35 Million CNY | -32.03% |
| 2023 Q4 | 182.45 Million CNY | -6.42% |
| 2023 Q1 | 245.67 Million CNY | -42.03% |
| 2023 FY | 779.71 Million CNY | -21.28% |
| 2023 Q2 | 193.76 Million CNY | -21.13% |
| 2023 Q3 | 194.98 Million CNY | 0.63% |
| 2022 Q3 | 249.31 Million CNY | 40.39% |
| 2022 Q2 | 177.59 Million CNY | 27.0% |
| 2022 Q1 | 139.83 Million CNY | -65.27% |
| 2022 Q4 | 423.77 Million CNY | 69.97% |
| 2022 FY | 990.51 Million CNY | 10.64% |
| 2021 Q4 | 402.6 Million CNY | 100.05% |
| 2021 Q1 | 116.67 Million CNY | -58.46% |
| 2021 Q3 | 201.24 Million CNY | 15.16% |
| 2021 FY | 895.29 Million CNY | 28.19% |
| 2021 Q2 | 174.76 Million CNY | 49.78% |
| 2020 Q3 | 155.96 Million CNY | 21.41% |
| 2020 FY | 698.38 Million CNY | -3.16% |
| 2020 Q1 | 133.07 Million CNY | -53.78% |
| 2020 Q2 | 128.46 Million CNY | -3.47% |
| 2020 Q4 | 280.88 Million CNY | 80.09% |
| 2019 FY | 721.21 Million CNY | -10.62% |
| 2019 Q1 | 152.55 Million CNY | -42.81% |
| 2019 Q2 | 113.04 Million CNY | -25.9% |
| 2019 Q4 | 287.93 Million CNY | 71.72% |
| 2019 Q3 | 167.67 Million CNY | 48.32% |
| 2018 Q4 | 266.75 Million CNY | 37.39% |
| 2018 Q2 | 172.95 Million CNY | -0.05% |
| 2018 FY | 806.9 Million CNY | 18.07% |
| 2018 Q1 | 173.03 Million CNY | -26.65% |
| 2018 Q3 | 194.15 Million CNY | 12.26% |
| 2017 FY | 683.42 Million CNY | 25.86% |
| 2017 Q4 | 235.89 Million CNY | 45.51% |
| 2017 Q3 | 162.11 Million CNY | -0.41% |
| 2017 Q2 | 162.78 Million CNY | 32.75% |
| 2017 Q1 | 122.62 Million CNY | -26.27% |
| 2016 Q3 | 137.32 Million CNY | 14.45% |
| 2016 Q2 | 119.98 Million CNY | 0.61% |
| 2016 Q4 | 166.32 Million CNY | 21.12% |
| 2016 Q1 | 119.25 Million CNY | 10.98% |
| 2016 FY | 542.99 Million CNY | 79.8% |
| 2015 FY | 301.99 Million CNY | 10.85% |
| 2015 Q2 | 73.81 Million CNY | 11.49% |
| 2015 Q4 | 107.44 Million CNY | 97.03% |
| 2015 Q3 | 54.53 Million CNY | -26.12% |
| 2015 Q1 | 66.2 Million CNY | -27.01% |
| 2014 Q2 | 57.47 Million CNY | 12.01% |
| 2014 Q1 | 51.31 Million CNY | -24.88% |
| 2014 FY | 272.43 Million CNY | 34.53% |
| 2014 Q4 | 90.7 Million CNY | 24.36% |
| 2014 Q3 | 72.93 Million CNY | 26.9% |
| 2013 Q4 | 68.31 Million CNY | 52.5% |
| 2013 FY | 202.5 Million CNY | 25.57% |
| 2013 Q3 | 44.79 Million CNY | -15.53% |
| 2013 Q2 | 53.02 Million CNY | 45.79% |
| 2013 Q1 | 36.37 Million CNY | -24.16% |
| 2012 FY | 161.26 Million CNY | 0.82% |
| 2012 Q2 | 40.37 Million CNY | 19.15% |
| 2012 Q3 | 39.04 Million CNY | -3.31% |
| 2012 Q4 | 47.95 Million CNY | 22.83% |
| 2012 Q1 | 33.88 Million CNY | -11.77% |
| 2011 Q2 | 47.91 Million CNY | 27.94% |
| 2011 Q1 | 37.45 Million CNY | 4.92% |
| 2011 Q3 | 36.18 Million CNY | -24.49% |
| 2011 Q4 | 38.41 Million CNY | 6.17% |
| 2011 FY | 159.95 Million CNY | 23.83% |
| 2010 Q1 | 24.07 Million CNY | -45.33% |
| 2010 Q2 | 35.7 Million CNY | 48.34% |
| 2010 Q3 | 33.69 Million CNY | -5.63% |
| 2010 Q4 | 35.69 Million CNY | 5.93% |
| 2010 FY | 129.17 Million CNY | -17.76% |
| 2009 FY | 157.07 Million CNY | -59.73% |
| 2009 Q1 | 32.14 Million CNY | -80.98% |
| 2009 Q2 | 43.45 Million CNY | 35.17% |
| 2009 Q3 | 37.43 Million CNY | -13.84% |
| 2009 Q4 | 44.03 Million CNY | 17.62% |
| 2008 Q3 | 108.66 Million CNY | 32.63% |
| 2008 Q4 | 169.01 Million CNY | 55.53% |
| 2008 Q2 | 81.93 Million CNY | 169.13% |
| 2008 Q1 | 30.44 Million CNY | -73.63% |
| 2008 FY | 390.06 Million CNY | 53.78% |
| 2007 FY | 253.65 Million CNY | -7.65% |
| 2007 Q2 | 31.59 Million CNY | -49.42% |
| 2007 Q1 | 62.45 Million CNY | -46.69% |
| 2007 Q3 | 44.15 Million CNY | 39.79% |
| 2007 Q4 | 115.44 Million CNY | 161.42% |
| 2006 Q1 | 79.92 Million CNY | -8.7% |
| 2006 Q4 | 117.14 Million CNY | 187.53% |
| 2006 Q3 | 40.74 Million CNY | 10.61% |
| 2006 Q2 | 36.83 Million CNY | -53.92% |
| 2006 FY | 274.65 Million CNY | 2.99% |
| 2005 Q2 | 31.59 Million CNY | -63.24% |
| 2005 FY | 266.66 Million CNY | -19.2% |
| 2005 Q1 | 85.96 Million CNY | -13.46% |
| 2005 Q3 | 61.56 Million CNY | 94.83% |
| 2005 Q4 | 87.54 Million CNY | 42.2% |
| 2004 Q2 | 57.94 Million CNY | -41.68% |
| 2004 Q1 | 99.34 Million CNY | 5.91% |
| 2004 FY | 330.01 Million CNY | 10.38% |
| 2004 Q4 | 99.32 Million CNY | 35.32% |
| 2004 Q3 | 73.39 Million CNY | 26.67% |
| 2003 Q2 | 66.38 Million CNY | 3.78% |
| 2003 FY | 298.98 Million CNY | 23.99% |
| 2003 Q1 | 63.96 Million CNY | -20.37% |
| 2003 Q4 | 93.8 Million CNY | 25.36% |
| 2003 Q3 | 74.82 Million CNY | 12.71% |
| 2002 Q2 | 59.13 Million CNY | 3.63% |
| 2002 FY | 241.13 Million CNY | -14.44% |
| 2002 Q3 | 44.62 Million CNY | -24.54% |
| 2002 Q4 | 80.32 Million CNY | 80.03% |
| 2002 Q1 | 57.05 Million CNY | 0.0% |
| 2001 FY | 281.83 Million CNY | 398.07% |
| 2000 FY | 56.58 Million CNY | 224.25% |
| 1999 FY | 17.45 Million CNY | 97.74% |
| 1998 FY | 8.82 Million CNY | 44.0% |
| 1997 FY | 6.12 Million CNY | 67.67% |
| 1996 FY | 3.65 Million CNY | 37.12% |
| 1995 FY | 2.66 Million CNY | 3.09% |
| 1994 FY | 2.58 Million CNY | 20.5% |
| 1993 FY | 2.14 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 14.38 Billion CNY | 94.31% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.3 Billion CNY | 37.499% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.14 Billion CNY | 74.008% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 1.08 Billion CNY | 24.636% |
| Aurora Optoelectronics Co.,Ltd. | 482.31 Million CNY | -69.698% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 64.1 Million CNY | -1176.855% |
| NanJing Pharmaceutical Company Limited | 2.3 Billion CNY | 64.504% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.08 Billion CNY | 24.86% |